全文获取类型
收费全文 | 10010992篇 |
免费 | 654522篇 |
国内免费 | 158140篇 |
专业分类
耳鼻咽喉 | 130938篇 |
儿科学 | 281735篇 |
妇产科学 | 231777篇 |
基础医学 | 1239691篇 |
口腔科学 | 264212篇 |
临床医学 | 1011493篇 |
内科学 | 1664345篇 |
皮肤病学 | 203635篇 |
神经病学 | 722630篇 |
特种医学 | 376361篇 |
外国民族医学 | 1681篇 |
外科学 | 1324637篇 |
综合类 | 717985篇 |
现状与发展 | 519篇 |
一般理论 | 3726篇 |
预防医学 | 797774篇 |
眼科学 | 228560篇 |
药学 | 866972篇 |
3061篇 | |
中国医学 | 214956篇 |
肿瘤学 | 536966篇 |
出版年
2022年 | 81003篇 |
2021年 | 179473篇 |
2020年 | 142525篇 |
2019年 | 145891篇 |
2018年 | 178113篇 |
2017年 | 158921篇 |
2016年 | 154287篇 |
2015年 | 196960篇 |
2014年 | 281695篇 |
2013年 | 372465篇 |
2012年 | 524838篇 |
2011年 | 569708篇 |
2010年 | 386708篇 |
2009年 | 347499篇 |
2008年 | 485016篇 |
2007年 | 505324篇 |
2006年 | 482412篇 |
2005年 | 444180篇 |
2004年 | 389775篇 |
2003年 | 360855篇 |
2002年 | 331995篇 |
2001年 | 312033篇 |
2000年 | 309894篇 |
1999年 | 263412篇 |
1998年 | 103337篇 |
1997年 | 90379篇 |
1996年 | 84401篇 |
1995年 | 83270篇 |
1994年 | 75565篇 |
1993年 | 64594篇 |
1992年 | 182546篇 |
1991年 | 176948篇 |
1990年 | 171517篇 |
1989年 | 166441篇 |
1988年 | 153830篇 |
1987年 | 149819篇 |
1986年 | 142671篇 |
1985年 | 136042篇 |
1984年 | 103412篇 |
1983年 | 88633篇 |
1982年 | 56301篇 |
1979年 | 92732篇 |
1978年 | 66504篇 |
1977年 | 57212篇 |
1976年 | 53091篇 |
1975年 | 58186篇 |
1974年 | 67232篇 |
1973年 | 64161篇 |
1972年 | 59371篇 |
1971年 | 54987篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
Lei Qi Mingxing Wang Yuehui Jia Yuanyuan Wang Liangfang Xue Linlin Du Shuxiu Hao Shengqi Su Ruixiang Wang Huixin Sun Chen Feng Guijin Li Qingyu Zeng Cunqi Lv Jiacheng Li Qi Li Yunyan Zhang Tong Wang 《International journal of cancer. Journal international du cancer》2023,153(6):1172-1181
Information regarding the impact of the coronavirus disease 2019 (COVID-19) pandemic on cervical cancer in mainland China is lacking. We explored its impact on the hospital attendance of patients with primary cervical cancer. We included 1918 patients with primary cervical cancer who initially attended Harbin Medical University Cancer Hospital between January 23, 2019, and January 23, 2021. Attendance decreased by 31%, from 1135 in 2019 to 783 in 2020, mainly from January to June (𝜒2 = 73.362, P < .001). The percentage of patients detected by screening decreased from 12.1% in January-June 2019 to 5.8% in January-June 2020 (𝜒2 = 7.187, P = .007). Patients with stage I accounted for 28.4% in 2020 significantly lower than 36.6% in 2019 (𝜒2 = 14.085, P < .001), and patients with stage III accounted for 27.1% in 2020 significantly higher than 20.5% in 2019 (𝜒2 = 11.145, P < .001). Waiting time for treatment was extended from 8 days (median) in January-June and July-December 2019 to 16 days in January-June (𝜒2 = 74.674, P < .001) and 12 days in July-December 2020 (𝜒2 = 37.916, P < .001). Of the 179 patients who delayed treatment, 164 (91.6%) were for the reasons of the healthcare providers. Compared to 2019, the number of patients in Harbin or non-Harbin in Heilongjiang Province and outside the province decreased, and cross-regional medical treatment has been hindered. The COVID-19 pandemic has negatively impacted cervical cancer patient attendance at the initial phase. These results are solid evidence that a strategy and mechanism for the effective attendance of cervical cancer patients in response to public health emergencies is urgently needed. 相似文献
72.
73.
74.
Nicla La Verde Agostino Riva Maria Silvia Cona Arianna Gabrieli Monica Cattaneo Cinzia Fasola Giuseppe Lipari Claudia De Stradis Valentina Favorito Benedetta Lombardi Stocchetti Davide Chizzoniti Alice Covizzi Eliana Rulli Francesca Galli Lorenzo Ruggieri Anna Gambaro Sabrina Ferrario Davide Dalu Maciej S. Tarkowski 《International journal of cancer. Journal international du cancer》2023,152(4):661-671
Previous studies on the immunogenicity of SARS-CoV-2 mRNA vaccines showed a reduced seroconversion in cancer patients. The aim of our study is to evaluate the immunogenicity of two doses of mRNA vaccines in solid cancer patients with or without a previous exposure to the virus. This is a single-institution, prospective, nonrandomized study. Patients in active treatment and a control cohort of healthy people received two doses of BNT162b2 (Comirnaty, BioNTech/Pfizer, The United States) or mRNA-1273 (Spikevax, Moderna). Vaccine was administered before starting anticancer therapy or on the first day of the treatment cycle. SARS-CoV-2 antibody levels against S1, RBD (to evaluate vaccine response) and N proteins (to evaluate previous infection) were measured in plasma before the first dose and 30 days after the second one. From January to June 2021, 195 consecutive cancer patients and 20 healthy controls were enrolled. Thirty-one cancer patients had a previous exposure to SARS-CoV-2. Cancer patients previously exposed to the virus had significantly higher median levels of anti-S1 and anti-RBD IgG, compared to healthy controls (P = .0349) and to cancer patients without a previous infection (P < .001). Vaccine type (anti-S1: P < .0001; anti-RBD: P = .0045), comorbidities (anti-S1: P = .0274; anti-RBD: P = .0048) and the use of G-CSF (anti-S1: P = .0151) negatively affected the antibody response. Conversely, previous exposure to SARS-CoV-2 significantly enhanced the response to vaccination (anti-S1: P < .0001; anti-RBD: P = .0026). Vaccine immunogenicity in cancer patients with a previous exposure to SARS-CoV-2 seems comparable to that of healthy subjects. On the other hand, clinical variables of immune frailty negatively affect humoral immune response to vaccination. 相似文献
75.
76.
Kjetil Andreas Hognestad Karlsen Sven Erik Gisvold Trond Nordseth Sigurd Fasting 《Acta anaesthesiologica Scandinavica》2023,67(10):1341-1347
Awake fibreoptic intubation has been considered a gold standard in the management of the difficult airway. However, failure may cause critical situations. The aim of this study was to investigate the incidence and causes of failed awake fibreoptic intubation at a tertiary care hospital. The study was conducted at St. Olav University Hospital in Trondheim, Norway. Problems occurring during anaesthesia are routinely recorded in the electronic anaesthesia information system (Picis Clinical Solutions Inc.), including difficult intubations. We applied text search on all anaesthesia records between 2011 and 2021 and identified 833 awake fibreoptic intubations. The anaesthesia records were examined to identify failed awake fibreoptic intubations, the cause of failure and how the airway ultimately was secured. Among 233,938 patients who received anaesthesia, 90,397 received tracheal intubation and 833 received awake fibreoptic intubation. Twenty-nine of the procedures failed. In nine patients the failure caused loss of airway control with desaturation and hypoventilation. The major causes of failure were dislodged tube after induction of general anaesthesia (n = 8), patient distress (n = 5), tube not able to pass (n = 5), and airway bleeding (n = 3). The situations were primarily solved using direct laryngoscopy, with or without bougie, or with video laryngoscopy. Tracheostomy was performed in four patients. Awake fibreoptic intubation failed in 3.5% of patients, most often due to dislocation, problems passing the tracheal tube, or patient discomfort. The failure rate was higher than in previous studies. 相似文献
77.
目的 为给兽药减量政策的制定、动物源性食品安全的维护提供理论依据。方法 利用每日允许摄入量(ADI)、估算每日摄入量(EDI)及慢性风险熵(CRQ),对中国居民通过摄入肉蛋乳等动物性食品暴露于吉他霉素的耐药性风险进行点评估。结果 随着年龄增长,中国居民的吉他霉素膳食暴露量逐渐降低。2~7岁人群吉他霉素的膳食暴露量最高,男女分别为2.17和2.29 μg/ ( kg·bw·d);>65岁人群膳食暴露量最低,男女分别为0.45和0.46 μg/ ( kg·bw·d)。2~7岁人群通过摄入乳制品的吉他霉素的膳食暴露量最大,男女分别为1.15和1.22 μg/ ( kg·bw·d),8岁以上人群通过摄入肉类食品的吉他霉素的膳食暴露量最大。中国居民通过摄入肉蛋乳等动物性食品暴露于吉他霉素,各年龄段CRQ均小于1。其中2~7岁人群CRQ值最高,风险最大;65岁以上人群CRQ值最低,风险最小。结论 中国居民通过摄入动物性食品的吉他霉素耐药性风险较低,危害程度较小,但儿童通过摄入乳制品的吉他霉素耐药性风险较高,有必要制定乳制品中吉他霉素残留的限量标准。 相似文献
78.